The first studies of relaxin on cell cultures has revealed that relaxin promotes and enhances oligodendricyte differentiation, maturation and meylin production 400% over controls. 

BVBiomed Ltd. presented the latest work on relaxin in the animal model of multiple sclerosis EAE. The positive results in this study support relaxin as a potential new treatment of multiple sclerosis.